# US 2024/0197600 A1 · Mouthwash Compositions and Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197600 A1
- Document ID: US20240197600A1
- Status: Published application
- Kind: A1
- Application number: 18/531,033
- Filed: 2023-12-06
- Published: 2024-06-20
- Earliest claimed: 2022-12-06
- Applicants: Colgate-Palmolive Company
- Inventors: Nihal DOGU; Betty WON; Paloma PIMENTA; Lyndsay SCHAEFFER-KORBYLO; Joseph Allan McKinnon STEELE; Lisa Marie MANUS; Lauren EVANS; Michael NORTH
- Web page: https://patentgrep.com/patent/US20240197600A1

## CPC

- A61K 8/466: {containing sulfonic acid derivatives; Salts}
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/4926: {having six membered rings}
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61Q 17/005: {Antimicrobial preparations}
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/52: Stabilizers
- A61K 2800/592: Mixtures of compounds complementing their respective functions
- A61K 2800/92: Oral administration
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

This application relates to novel anti-bacterial mouthwash compositions comprising hyaluronic acid, cetyl pyridinium chloride, and taurate surfactant, having unexpected stability, and their use in treating plaque, gingivitis, bad breath, implant infections, tooth decay, inflammation, and dental staining, as well as helping to moisturize and protect the teeth and gums.

## Claims

### Claim 1

An antibacterial mouthwash composition comprising hyaluronic acid (HA), cetyl pyridinium chloride (CPC), an effective amount of a taurate surfactant represented by Formula (1):
wherein R1 is a saturated or unsaturated, straight or branched C7-17 alkyl, R2 is H or methyl, and M+ is H, sodium, or potassium; and at least 70% water, by weight of the composition.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the taurate surfactant is sodium methyl cocoyl taurate.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the taurate surfactant is sodium methyl cocoyl taurate in an amount of 0.3% to 0.8% by weight.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the amount of CPC is 0.05 to 0.1% by weight.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the amount of HA corresponds to 0.05 to 0.5% by weight of sodium hyaluronate.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the average molecular weight of the HA is between 300 kD and 1 MDa.

### Claim 7 (depends on 1)

The composition of claim 1, further comprising a zinc salt.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the zinc salt is zinc lactate in an amount of 0.1% to 0.5%, by weight.

### Claim 9 (depends on 1)

The composition of claim 1, further comprising a fluoride ion source.

### Claim 10 (depends on 1)

The composition of claim 1, further comprising a nonionic surfactant.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the nonionic surfactant is poloxamer 407 in the amount of 0.3% to 0.5% by weight.

### Claim 12 (depends on 1)

The composition of claim 1, further comprising a humectant.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the pH is between pH 4 and pH 5.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the delivery of CPC to the teeth is enhanced relative to a formulation having PEG-40 hydrogenated castor oil in place of a taurate surfactant, and/or wherein the antibacterial activity as measured in a short-interval kill test (SIKT) is superior to a formulation having PEG-40 hydrogenated castor oil in place of a taurate surfactant.

### Claim 15 (depends on 1)

The composition of claim 1, which does not form a cetylpyridinum hyaluronate precipitate in a freeze-thaw cycling test, or after four weeks of aging at 40° C., or after four weeks of aging at −10° C.

### Claim 16 (depends on 1)

The composition of claim 1 which is free of ethanol, PEG-40 hydrogenated castor oil, betaine surfactants, sodium lauryl sulfate, and/or any ionic surfactants other than sodium methyl cocoyl taurate.

### Claim 17 (depends on 1)

The composition of claim 1 which is formed by combining ingredients comprising:
a. 0.05 to 0.15% sodium hyaluronate,
b. 0.05 to 0.1% cetyl pyridinium chloride,
c. 0.3% to 0.8% sodium methyl cocoyl taurate, and
d. 75% to 85% water,
and optionally further comprising one or more of zinc ion sources, humectants, non-ionic surfactants, fluoride ion sources, humectants, preservatives, sweeteners, flavorings, and/or dyes,
wherein all percentages are by weight of the composition.

### Claim 18 (depends on 1)

The composition of claim 1 which is formed by combining ingredients comprising:
a. 0.05-0.15% sodium hyaluronate,
b. 0.07-0.08% cetyl pyridinium chloride,
c. 0.4-0.5% sodium methyl cocoyl taurate,
d. 0.2-0.4% zinc L-lactate dihydrate, and
e. 75-85% water,
wherein all percentages are by weight of the composition.

### Claim 19 (depends on 1)

The composition of claim 1 which is formed by combining ingredients comprising:
a. 0.05-0.15% sodium hyaluronate,
b. 0.07-0.08% cetyl pyridinium chloride,
c. 0.4-0.5% sodium methyl cocoyl taurate,
d. 0.2-0.4% zinc L-lactate dihydrate,
e. 15-20% humectants comprising glycerin, propylene glycol, and sorbitol,
f. 0.3-0.5% poloxamer 407,
g. 0.04-0.06% L-lactic acid,
h. 0.04-0.06% sodium fluoride,
i. 0.02-0.03% sweetener comprising sucralose and sodium saccharin,
j. 0.05-0.2% flavoring comprising one or more cooling agents,
k. 0.01-0.15% preservatives, selected from potassium sorbate, sodium benzoate, and combinations thereof,
l. 0.00005 -0.0005% water-soluble dye, and
m. 75-85% water,
wherein all percentages are by weight of the composition.

### Claim 20

(canceled)

### Claim 21 (depends on 1)

A method of treatment or prophylaxis of one or more of xerostomia, plaque, gingivitis, bad breath, dental implant infections, tooth decay, and/or caries; or of reducing inflammation in the oral cavity; or of reducing dental staining, comprising administering to the oral cavity of a subject in need thereof a composition according to claim 1.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

(canceled)
